Sean C. Dowdy

ORCID: 0000-0003-2092-7551
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Uterine Myomas and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Endometriosis Research and Treatment
  • Enhanced Recovery After Surgery
  • Anesthesia and Pain Management
  • Cervical Cancer and HPV Research
  • Virus-based gene therapy research
  • Intraperitoneal and Appendiceal Malignancies
  • Cancer-related molecular mechanisms research
  • Clinical practice guidelines implementation
  • Cancer, Lipids, and Metabolism
  • Epigenetics and DNA Methylation
  • Colorectal Cancer Surgical Treatments
  • Endoplasmic Reticulum Stress and Disease
  • Genomics, phytochemicals, and oxidative stress
  • Animal Genetics and Reproduction
  • Surgical site infection prevention
  • Genetic factors in colorectal cancer
  • Biomedical and Engineering Education
  • Estrogen and related hormone effects
  • Nausea and vomiting management
  • RNA modifications and cancer
  • Cancer-related gene regulation

Mayo Clinic
2016-2025

WinnMed
2014-2025

Mayo Clinic in Arizona
2016-2025

Mayo Clinic in Florida
2009-2024

Community Link
2024

Women’s Health Care
2024

Hesco (United States)
2023

Check Point (Israel)
2023

S.P.E.C.I.E.S.
2023

Anna Needs Neuroblastoma Answers
2023

<h3>Background</h3> This is the first updated Enhanced Recovery After Surgery (ERAS) Society guideline presenting a consensus for optimal perioperative care in gynecologic/oncology surgery. <h3>Methods</h3> A database search of publications using Embase and PubMed was performed. Studies on each item within ERAS protocol were selected with emphasis meta-analyses, randomized controlled trials, large prospective cohort studies. These studies then reviewed graded according to Grading...

10.1136/ijgc-2019-000356 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2019-03-15

The “Guidelines for Pre- and Intra-operative Care in Gynecologic/Oncology Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part I,” [1] examined the evidence surrounding care elements including preoperative medical optimization, bowel preparation, carbohydrate loading, thromboembolism prophylaxis, skin standard anesthetic protocol intraoperative fluid management. goal of this article is to critically review existing make recommendations postoperative care.

10.1016/j.ygyno.2015.12.019 article EN cc-by-nc-nd Gynecologic Oncology 2016-01-04

In Brief OBJECTIVE: Residual disease after initial surgery for ovarian cancer is the strongest prognostic factor survival. However, extent of surgical resection required to achieve optimal cytoreduction controversial. Our goal was estimate effect aggressive on patient METHODS: A retrospective cohort study consecutive patients with International Federation Gynecology and Obstetrics stage IIIC undergoing primary conducted between January 1, 1994, December 31, 1998. The main outcome measures...

10.1097/01.aog.0000192407.04428.bb article EN Obstetrics and Gynecology 2006-01-01

•We provide evidence supporting pre- and intra-operative management of patients undergoing gynecologic/oncology surgery.•This guideline will help integrate knowledge into practice, align perioperative care, encourage future investigations.

10.1016/j.ygyno.2015.11.015 article EN cc-by-nc-nd Gynecologic Oncology 2015-11-18

10.1016/j.ccell.2017.02.010 article EN Cancer Cell 2017-03-01

Molecular classification of high-grade serous ovarian cancer (HGSOC) using transcriptional profiling has proven to be complex and difficult validate across studies. We determined gene expression profiles 174 well-annotated HGSOCs demonstrate prognostic significance the prespecified TCGA Network signatures. Furthermore, we confirm presence four HGSOC subtypes a de novo classification. Survival differed statistically significantly between (log rank, P = .006) was best for immunoreactive-like...

10.1093/jnci/dju249 article EN JNCI Journal of the National Cancer Institute 2014-09-30

Edmonston vaccine strains of measles virus (MV) have shown significant antitumor activity in preclinical models ovarian cancer. We engineered MV to express the marker peptide carcinoembryonic antigen (MV-CEA virus) also permit real-time monitoring viral gene expression tumors clinical setting. Patients with Taxol and platinum-refractory recurrent cancer normal CEA levels were eligible for this phase I trial. Twenty-one patients treated MV-CEA i.p. every 4 weeks up 6 cycles at seven different...

10.1158/0008-5472.can-09-2762 article EN Cancer Research 2010-01-27

To investigate the effects of enhanced recovery (a multimodal perioperative care enhancement protocol) in patients undergoing gynecologic surgery.Consecutive managed under an pathway and cytoreduction, surgical staging, or pelvic organ prolapse surgery between June 20, 2011, December were compared with consecutive historical controls (March to 2010) matched by procedure. Wilcoxon rank-sum, χ, Fisher's exact tests used for comparisons. Direct medical costs incurred first 30 days obtained from...

10.1097/aog.0b013e31829aa780 article EN Obstetrics and Gynecology 2013-07-09
Tracy A. O’Mara Dylan M. Glubb Frédéric Amant Daniela Annibali Katie A. Ashton and 95 more John Attia Paul L. Auer Matthias W. Beckmann Amanda Black Manjeet K. Bolla Hiltrud Brauch Hermann Brenner Louise A. Brinton Daniel D. Buchanan Barbara Burwinkel Jenny Chang‐Claude Stephen J. Chanock Chu Chen Maxine Chen Timothy Cheng Christine L. Clarke Mark Clendenning Linda S. Cook Fergus J. Couch Angela Cox Marta Crous‐Bou Kamila Czene Felix R. Day Joe Dennis Jeroen Depreeuw Jennifer A. Doherty Thilo Dörk Sean C. Dowdy Matthias Dürst Arif B. Ekici Peter A. Fasching Brooke L. Fridley Christine M. Friedenreich Lin Fritschi Jenny N. Fung Montserrat García‐Closas Mia M. Gaudet Graham G. Giles Ellen L. Goode Maggie Gorman Christopher A. Haiman Per Hall Susan E. Hankison Catherine S. Healey Alexander Hein Peter Hillemanns Shirley Hodgson Erling A. Høivik Elizabeth Holliday John L. Hopper David J. Hunter Angela Jones Camilla Krakstad Vessela N. Kristensen Diether Lambrechts Loı̈c Le Marchand Xiaolin Liang Annika Lindblom Jolanta Lissowska Jirong Long Lingeng Lu Anthony M. Magliocco Lynn Martin Mark McEvoy Alfons Meindl Kyriaki Michailidou Roger L. Milne Miriam Mints Grant W. Montgomery Rami Nassir Håkan Olsson Irene Orlow Geoffrey Otton Claire Palles John R. B. Perry Julian Peto Loreall Pooler Jennifer Prescott Tony Proietto Timothy R. Rebbeck Harvey A. Risch Peter A. W. Rogers Matthias Rübner Ingo B. Runnebaum Carlotta Sacerdote Gloria E. Sarto Fredrick R. Schumacher Rodney J. Scott Veronica Wendy Setiawan Mitul Shah Xin Sheng Xiao‐Ou Shu Melissa C. Southey Anthony J. Swerdlow Emma Tham

Endometrial cancer is the most commonly diagnosed of female reproductive tract in developed countries. Through genome-wide association studies (GWAS), we have previously identified eight risk loci for endometrial cancer. Here, present an expanded meta-analysis 12,906 cases and 108,979 controls (including new genotype data 5624 cases) identify nine novel significant loci, including a locus on 12q24.12 by meta-GWAS colorectal At five expression quantitative trait (eQTL) analyses candidate...

10.1038/s41467-018-05427-7 article EN cc-by Nature Communications 2018-08-03

To estimate lower extremity lymphedema prevalence in patients surgically treated for endometrial cancer, identify predictors of lymphedema, and evaluate the effects on quality life.One thousand forty-eight consecutive who were operated between 1999 2008 at Mayo Clinic mailed a survey, which included our validated 13-item screening questionnaire two quality-of-life measures. Logistic regression models fit to factors associated with prevalent lymphedema; multivariable model was obtained using...

10.1097/aog.0000000000000372 article EN Obstetrics and Gynecology 2014-07-08

Objective: The aim of this study was to conduct a prospective, multicenter survey patients regarding postoperative opioid use inform development standardized, evidence-based, procedure-specific prescribing guidelines. Summary Background Data: Previous work has shown significant variation in the amount opioids prescribed after elective procedures, calling for optimization prescribing. Methods: Adults (n = 3412) undergoing 25 procedures were identified prospectively from 3 academic centers...

10.1097/sla.0000000000002919 article EN Annals of Surgery 2018-07-14

Summary This international multidisciplinary consensus statement was developed to provide balanced guidance on the safe peri‐operative use of opioids in adults. An panel healthcare professionals evaluated literature relating postoperative opioid‐related harm, including persistent opioid use; opioid‐induced ventilatory impairment; non‐medical diversion and dependence; driving under influence prescription opioids. Recommended strategies reduce harm include pre‐operative assessment risk an...

10.1111/anae.15262 article EN Anaesthesia 2020-10-07

Purpose Identify features on preoperative computed tomography (CT) scans to predict suboptimal primary cytoreduction in patients treated for advanced ovarian cancer institution A. Reciprocally cross validate the predictors identified with those from two previously published cohorts institutions B and C. Patients Methods Preoperative CT stage III/IV epithelial who underwent A between 1999 2005 were retrospectively reviewed by radiologists blinded surgical outcome. Fourteen criteria assessed....

10.1200/jco.2006.07.7800 article EN Journal of Clinical Oncology 2007-02-01

Computed tomography (CT) scans of the abdomen and pelvis may predict which patients with ovarian carcinoma can undergo optimal cytoreduction at primary surgery. Previous studies have demonstrated that had rates ranging from 50-60%. The authors sought to determine whether these findings applied a surgical practice higher rate debulking. A predictive model using CT scanning CA 125 values would allow be more appropriately treated neoadjuvant chemotherapy.Preoperative for Stage III/IV (according...

10.1002/cncr.20376 article EN Cancer 2004-06-02

Edmonston vaccine strains of measles virus (MV) have significant antitumor activity in mouse xenograft models ovarian cancer. MV engineered to express the sodium iodide symporter gene (MV-NIS) facilitates localization viral expression and offers a tool for tumor radiovirotherapy. Here, we report results from clinical evaluation MV-NIS patients with taxol- platinum-resistant was given intraperitoneally every 4 weeks up 6 cycles. Treatment well tolerated associated promising median overall...

10.1158/0008-5472.can-14-2533 article EN Cancer Research 2014-11-15
Coming Soon ...